IDH-mutant and 1p/19q-codeleted oligodendroglioma
MONDO:0859592An anaplastic oligodendroglioma that has material basis in IDH gene family mutation and combined whole-arm losses of 1p and 19q (1p/19q codeletion).
2831 clinical trials for this condition and its sub-types, 9 tagged with IDH-mutant and 1p/19q-codeleted oligodendroglioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of IDH-mutant and 1p/19q-codeleted oligodendroglioma
-
Brain tumor patients may skip radiation to save thinking skills
Disease control CompletedThis phase 3 trial tested whether giving only PCV chemotherapy, instead of chemotherapy plus radiotherapy, could protect thinking abilities in people with a specific brain tumor (1p/19q codeleted anaplastic glioma). 280 newly diagnosed adults were randomly assigned to receive eit…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Brain tumor patients prefer virtual visits? new study investigates
Symptom relief CompletedThis study looked at whether video doctor visits (telehealth) work as well as in-person visits for people with brain tumors (gliomas) who are taking oral chemotherapy. 30 patients took part, alternating between telehealth and in-person checkups. The goal was to see which type of …
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC